Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QT prolongation with domperidone in routine hospital care
NL-OMON28199Withdrawn
- Sponsor
- Erasmus MC
- Start
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of domperidone in Nausea and Vomiting, sponsored by Erasmus MC. Primary endpoint: QTc time on ECG. Planned start Jun 2014; status: withdrawn.
02
Drugs
domperidone
03
Conditions
Nausea and Vomiting
Beyond the preview
Go deeper on NL-OMON28199.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON28199.